Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
| Revenue (TTM) | $9.47B |
| Gross Profit (TTM) | $6.81B |
| EBITDA | $4.07B |
| Operating Margin | 34.70% |
| Return on Equity | 66.00% |
| Return on Assets | 15.30% |
| Revenue/Share (TTM) | $21.35 |
| Book Value | $7.84 |
| Price-to-Book | 14.66 |
| Price-to-Sales (TTM) | 5.40 |
| EV/Revenue | 5.89 |
| EV/EBITDA | 13.70 |
| Quarterly Earnings Growth (YoY) | 6.10% |
| Quarterly Revenue Growth (YoY) | 3.00% |
| Shares Outstanding | $422.13M |
| Float | $421.30M |
| % Insiders | 0.16% |
| % Institutions | 101.07% |
Volatility is currently expanding